BGBrett C. Geiger

Brett C. Geiger

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Brett C. Geiger has a total of 15 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Top Cited Papers

    Cartilage-penetrating nanocarriers improve delivery and efficacy of growth factor treatment of osteoarthritis

    by Brett C. Geiger, Sheryl Wang, Robert F. Padera, Alan J. Grodzinsky, Paula T. Hammond

    A charged molecular carrier enables sustained growth factor delivery to cartilage, demonstrating therapeutic benefit in a rat model of osteoarthritis.


  • Open Access

    Synthetic nanoscale electrostatic particles as growth factor carriers for cartilage repair

    by Nisarg J. Shah, Brett C. Geiger, Mohiuddin A. Quadir, Nasim Hyder, Yamini Krishnan, Alan J. Grodzinsky, Paula T. Hammond

    The efficient transport of biological therapeutic materials to target tissues within the body is critical to their efficacy. In cartilage tissue, the lack of blood vessels prevents the entry of systemically administered drugs at therapeutic levels. Within the articulating joint complex, the dense and highly charged extracellular matrix (ECM) hinders the transport of locally administered therapeutic molecules. Consequently, cartilage injury is difficult to treat and frequently results in debilitating osteoarthritis. Here we show a generalizable approach in which the electrostatic assembly of synthetic polypeptides and a protein, insulin‐like growth factor‐1 (IGF‐1), can be used as an early interventional therapy to treat injury to the cartilage. We demonstrated that poly(glutamic acid) and poly(arginine) associated with the IGF‐1 via electrostatic interactions, forming a net charged nanoscale polyelectrolyte complex (nanoplex). We observed that the nanoplex diffused into cartilage plugs in vitro and stimulated ECM production. In vivo, we monitored the transport, retention and therapeutic efficacy of the nanoplex in an established rat model of cartilage injury. A single therapeutic dose, when administered within 48 hr of the injury, conferred protection against cartilage degradation and controlled interleukin‐1 mediated inflammation. IGF‐1 contained in the nanoplex was detected in the joint space for up to 4 weeks following administration and retained bioactivity. The results indicate the potential of this approach as an early intervention therapy following joint injury to delay or even entirely prevent the onset of osteoarthritis.


  • Encasement of metallic cardiovascular stents with endothelial cell‐selective copolyetheresterurethane microfibers

    by Tilman Sauter, Brett Geiger, Karl Kratz, Andreas Lendlein

    Cardiovascular metallic stents established in clinical application are typically coated by a thin polymeric layer on the stent struts to improve hemocompatibility, whereby often a drug is added to the coating to inhibit neointimal hyperplasia. Besides such thin film coatings recently nano/microfiber coated stents are investigated, whereby the fibrous coating was applied circumferential on stents. Here, we explored whether a thin fibrous encasement of metallic stents with preferentially longitudinal aligned fibers and different local fiber densities can be achieved by electrospinning. An elastic degradable copolyetheresterurethane, which is reported to selectively enhance the adhesion of endothelial cells, while simultaneously rejecting smooth muscle cells, was utilized for stent coating. The fibrous stent encasements were microscopically assessed regarding their single fiber diameters, fiber covered area and fiber alignment at three characteristic stent regions before and after stent expansion. Stent coatings with thicknesses in the range from 30 to 50 µm were achieved via electrospinning with 1,1,1,3,3,3‐hexafluoro‐2‐propanol (HFP)‐based polymer solution, while a mixture of HFP and formic acid as solvent resulted in encasements with a thickness below 5 µm comprising submicron sized single fibers. All polymeric encasements were mechanically stable during expansion, whereby the fibers deposited on the struts remained their position. The observed changes in fiber density and diameter indicated diverse local deformation mechanisms of the microfibers at the different regions between the struts. Based on these results it can be anticipated that the presented fibrous encasement of stents might be a promising alternative to stents with polymeric strut coatings releasing anti‐proliferative drugs. Copyright © 2015 John Wiley & Sons, Ltd.


  • Dual drug release from CO2‐infused nanofibers via hydrophobic and hydrophilic interactions

    by Brett C. Geiger, Mark Tyler Nelson, Hrishikesh R. Munj, David L. Tomasko, John J. Lannutti

    This study investigated the effects of hydrophobic–hydrophilic interactions on dual drug release from CO2‐infused nanofibers scaffolds (PCL, PCL–gelatin, and PCL “core” PCL–gelatin “shell”) using BODIPY 493/503 and Rhodamine B fluorescent dyes as drug models. Favorable dye–scaffold interactions increased total dye loading and promoted steady, more linear release. Unfavorable dye–scaffold interactions reduced overall loading and led to a greater burst release of dye. However, when CO2 was used to infuse dye into an unfavorable scaffold, the changes in loading and release were less pronounced. When two dyes were infused, these behaviors were accentuated due to interactions between the dissolved forms of the dyes. Core–shell composite nanofibers displayed radically different release properties versus pure PCL–gelatin fibers when treated with dyes via CO2 infusion. Dye release from core–shell scaffolds was highly sensitive to both interactions with scaffolds and the phase of CO2 used to infuse the compounds of interest. By using different phases of CO2 to partition dyes into hydrophobic and hydrophilic sections of core–shell nanofibers, such interactions can be manipulated to develop a bimodal drug release system with potential application in drug delivery or tissue engineering. © 2015 Wiley Periodicals, Inc. J. Appl. Polym. Sci. 2015, 132, 42571.